background image

Paid Clinical Trials Chattanooga

Discover 122 paid clinical trials in Chattanooga, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period.

for
Chronic Lymphocytic Leukemia
Location: Chattanooga TN, Nashville TN, Cincinnati OH, Columbus OH,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT06524375

Phase2, Recruiting

A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo

for
Alopecia Areata, Vitiligo
Location: Chattanooga TN, Evans GA, Indianapolis IN, West Lafayette IN,
Sponsor: Dren Bio

Sex: All

Age: 18+

Code: NCT06602232

Phase1, Recruiting

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures

for
Generalized Epilepsy
Location: Chattanooga TN, Nashville TN, Birmingham AL, Lexington KY,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 70+

Code: NCT06425159

Phase2, Phase3, Recruiting

Different Doses of Oral Melatonin Supplements in Chronic Kidney Disease (CKD)-Associated Sleep Disorders

for
End Stage Renal Disease, Chronic Kidney Disease, Sleep Disorder
Location: Chattanooga TN
Sponsor: Southeast Renal Research Institute

Sex: All

Age: 18 - 70+

Code: NCT01922999

Phase2, Phase3, Recruiting

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Chattanooga TN, Nashville TN, Edgewood KY, Mobile AL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136559

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

By submitting, you consent to the use of your personal details, including contact information and location, to respond to your request for information related to clinical trials, as outlined in the Privacy Policy. If at any time you want to discontinue receiving alerts, please click the Unsubscribe link in the email received.

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Chattanooga TN, Nashville TN, Athens GA, Louisville KY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase3, Recruiting

A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)

for
Recurrent or Metastatic Solid Tumors
Location: Chattanooga TN, Nashville TN, Germantown TN, Skokie IL,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06330064

Phase2, Recruiting

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)

for
Brain Tumor, Recurrent, Brain Tumor, Brain Tumor, Primary,
Location: Chattanooga TN, Atlanta GA, Louisville KY, Cincinnati OH,
Sponsor: GT Medical Technologies, Inc.

Sex: All

Age: 0 - 70+

Code: NCT04427384

Recruiting

C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

for
HEPATITIS C VIRUS CHRONIC INFECTION
Location: Chattanooga TN, Marietta GA, Birmingham AL, Asheville NC,
Sponsor: Atea Pharmaceuticals, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06868264

Phase3, Recruiting

Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis

for
Deep Venous Thrombosis
Location: Chattanooga, TN
Sponsor: University of Tennessee

Sex: All

Age: 18 - 70+

Code: NCT01029821

Recruiting